Vident Advisory, LLC
- SEC CIK
- 0001744347
- Latest filing
- Aug 12, 2026
FOLD holding history
Amicus Therapeutics, Inc. in every 13F filed by Vident Advisory, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FOLD overviewAll 13F holders of FOLDFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −21,391−100.0% | Sold out | Holders |
| Q4 2025 | 21,391 | $304.6K | <0.1% | −3,574−14.3% | Reduced | Holders |
| Q3 2025 | 24,965 | $196.7K | <0.1% | +2,278+10.0% | Added | Holders |
| Q2 2025 | 22,687 | $130.0K | <0.1% | +10,230+82.1% | Added | Holders |
| Q1 2025 | 12,457 | $101.6K | <0.1% | +12,457 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −130,108−100.0% | Sold out | Holders |
| Q3 2024 | 130,108 | $1.39M | <0.1% | +21,229+19.5% | Added | Holders |
| Q2 2024 | 108,879 | $1.08M | <0.1% | +28,842+36.0% | Added | Holders |
| Q1 2024 | 80,037 | $942.8K | <0.1% | +13,202+19.8% | Added | Holders |
| Q4 2023 | 66,835 | $948.4K | <0.1% | +50,741+315.3% | Added | Holders |
| Q3 2023 | 16,094 | $195.7K | <0.1% | – | No prior filing | Holders |